This site is intended for health professionals only

Orion marketing authorisation application for formulation of Easyhaler®


Orion Corporation has submitted a marketing authorisation application for combined budesonide-formoterol formulation of the Easyhaler® product family in Europe.

Orion applies for approval in EU through decentralised procedure. The review process will commence once all involved member states have validated the application.


Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine